Jailani, Marvin .
HRN: 25-57-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/18/2026
02/24/2026
PO
5ml
TID
Amoebiasis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: